NYTech
Companies
Companyhealthcare ai

PozeSCAF Inc

Transforming Drug Discovery through AxDrug & Synthesis Expertise AxDrug, our state-of-the-art AI engine, revolutionizes the drug discovery landscape by swiftly identifying promising "hit" molecules with unparalleled accuracy. At PozeSCAF, we don't stop at identification. With our in-house chemistry lab, we design, synthesize, and deliver molecules to our clients, analyzing assay results and progressing to the Lead optimization stage. Global Reach, Local Excellence While headquartered in the U[1][2]

Visit website Suggest an update
2019 Founded7 People on the graph

Overview

PozeSCAF Inc is listed as a healthcare AI company in the New York AI scene[1]. The company operates in biotechnology research[3]. PozeSCAF develops AxDrug, an AI engine for drug discovery that identifies promising molecules[2]. Beyond identification, the company maintains an in-house chemistry laboratory where it designs, synthesizes, and delivers molecules to clients, with capabilities extending to assay analysis and lead optimization[2]. According to available employment data, the company has approximately 36 employees[3].

Business address: 94 Greene Ave, New York, New York, 11238. [6]

Growth & traction

LinkedIn lists 36 people working at PozeSCAF Inc. [4]

Leadership & org chart

Focus

  • PozeSCAF Inc describes itself as "AxDrug platform (AI & Computational chem) integrates synthesis: CRO services - Hit Identification to Lead Optimization.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.